Latino Cannabis Alliance Unites for Nationwide Collective Action – Heady NJ
The Latino cannabis research coalition is addressing significant gaps in cannabis science for Latino populations. This nationwide effort aims to improve evidence-based guidance for clinicians. It focuses on culturally competent research to better…
How Federal Cannabis Rescheduling Could Be Impacted by Attorney General Changes
Federal cannabis rescheduling impacts are significant for clinical research and patient access. Changes in the attorney general position could alter the rescheduling timeline. This uncertainty affects healthcare providers and patients alike.
Cannabis Rescheduling: Potential Distant Impacts on Healthcare Providers
The 2026 cannabis rescheduling impacts could transform healthcare providers' approach to cannabis use. Rescheduling may enable expanded research and clearer clinical guidelines. Providers must prepare for evolving policies and patient care challenges.
Long-term Cannabis Use Alters Brain Structure – FemaleFirst
Structural brain changes cannabis use is linked to alterations in regions critical for memory and impulse control. Chronic cannabis users may experience cognitive and behavioral effects. Clinicians should consider these changes when advising patients on…
Oliver’s Law: Campaign Calls for Changes to Medical Cannabis Prescribing in Psychiatric Conditions
Psychiatric cannabis prescribing guidelines are urgently needed as patients increasingly seek medical cannabis for psychiatric conditions despite limited clinical trial data. Oliver's Law campaign highlights this evidence gap and calls for regulatory…
Germany’s Cannabis Reform Shows No Signs of Harm its Critics Predicted, Government Data Reveals
German cannabis legalization remains controversial despite early data showing no major harms. The 2024 reform has not produced the negative outcomes critics predicted. This suggests regulated cannabis access can coexist with public health safeguards.
Canadian Cannabis Companies Eye US Medicare CBD Pilot Project – StratCann
Canadian cannabis companies are positioning themselves to participate in the Medicare hemp pilot program, reflecting growing interest in CBD reimbursement pathways. This pilot could significantly impact how cannabis-derived therapeutics are integrated…
Cannabis Compounds CBD and CBG Fatty Liver Benefits in 2026
Cannabis compounds CBD and CBG fatty liver benefits are gaining attention for their potential to reduce hepatic steatosis. These cannabinoids show promise in improving liver health and metabolic markers. Clinicians should consider emerging evidence when…
Hello from East Africa
Your endocannabinoid system doesn’t care about your zip code, but your local cannabinoid chemistry might. Turns out therapeutic potential is truly universal, even if regulatory frameworks aren’t. Via r/trees Further Reading Evidence…
Catching a whiff of weed in public got me like:
My olfactory system just conducted an impromptu cannabinoid identification test, and apparently I passed with flying colors. Via r/trees Further Reading Cannabis Policy WirePolicy Watch: 20 Regulatory Updates — March 20, 2026 Evidence…
